Company Filing History:
Years Active: 2017-2021
Title: Eva Jimenez-Mateos: Innovating Epilepsy Treatments
Introduction
Eva Jimenez-Mateos is a notable inventor based in Dublin, Ireland, who has made significant contributions to the field of neurology. With a focus on developing innovative treatments for seizure-related disorders, her work helps pave the way for improved healthcare options for those affected by epilepsy.
Latest Patents
Jimenez-Mateos holds two patents related to the inhibition of microRNA-134 for the treatment of seizure-related disorders and neurologic injuries. The first patent details a method for preventing or treating conditions such as epilepsy or status epilepticus by employing an agent capable of inhibiting the activity of miR-134. The second patent reinforces this methodology emphasizing the delivery of the agent directly to the brain, showcasing its potential therapeutic effects on individuals experiencing seizures or related brain disorders.
Career Highlights
In her professional journey, Eva Jimenez-Mateos is affiliated with the Royal College of Surgeons in Ireland. Her role at this esteemed institution allows her to collaborate with leading researchers and contribute to advancing medical science, particularly in neurology and epilepsy research.
Collaborations
Jimenez-Mateos works alongside David Henshall, a respected figure in the field. Their collaboration fosters a dynamic research environment, emphasizing the importance of teamwork in driving innovation and ensuring the success of their scientific endeavors.
Conclusion
Eva Jimenez-Mateos stands out as an innovator dedicated to improving treatments for epilepsy and neurological disorders. With her patents, she exemplifies the impact of innovation in medicine, aiming to enhance the quality of life for those affected by seizure-related conditions.